4.7 Article

Rseg-an R package to optimize segmentation of SNP array data

Journal

BIOINFORMATICS
Volume 27, Issue 3, Pages 419-420

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/bioinformatics/btq668

Keywords

-

Funding

  1. Nordic Center of Excellence
  2. EU
  3. John and Birthe Meyer Foundation
  4. Danish Council for Independent Research Medical Sciences
  5. Lundbeck Foundation
  6. Danish Cancer Society
  7. Danish Ministry of the Interior and Health

Ask authors/readers for more resources

The use of high-density SNP arrays for investigating copy number alterations in clinical tumor samples, with intra tumor heterogeneity and varying degrees of normal cell contamination, imposes several problems for commonly used segmentation algorithms. This calls for flexibility when setting thresholds for calling gains and losses. In addition, sample normalization can induce artifacts in the copy-number ratios for the non-changed genomic elements in the tumor samples. Results: We present an open source R package, Rseg, which allows the user to define sample-specific thresholds to call gains and losses. It also allows the user to correct for normalization artifacts.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences

Tenna Vesterman Henriksen, Noelia Tarazona, Amanda Frydendahl, Thomas Reinert, Francisco Gimeno-Valiente, Juan Antonio Carbonell-Asins, Shruti Sharma, Derrick Renner, Dina Hafez, Desamparados Roda, Marisol Huerta, Susana Rosello, Anders Husted Madsen, Uffe S. Love, Per Vadgaard Andersen, Ole Thorlacius-Ussing, Lene Hjerrild Iversen, Kare Andersson Gotschalck, Himanshu Sethi, Alexey Aleshin, Andres Cervantes, Claus Lindbjerg Andersen

Summary: The study demonstrates the strong prognostic value of serial postoperative ctDNA analysis in predicting recurrence and assessing tumor growth rate. The novel combination of ctDNA detection and growth rate assessment provides unique opportunities for guiding treatment decisions.

CLINICAL CANCER RESEARCH (2022)

Article Medical Laboratory Technology

Error Characterization and Statistical Modeling Improves Circulating Tumor DNA Detection by Droplet Digital PCR

Tenna Henriksen, Simon O. Drue, Amanda Frydendahl, Christina Demuth, Mads H. Rasmussen, Thomas Reinert, Jakob S. Pedersen, Claus L. Andersen

Summary: This study characterized noise in ddPCR assays and developed two novel ctDNA calling methods informed by assay-specific noise profiles. The results demonstrate that considering noise and DNA input amounts can improve the sensitivity and specificity of ctDNA detection.

CLINICAL CHEMISTRY (2022)

Article Oncology

Circulating tumor DNA for prognosis assessment and postoperative management after curative-intent resection of colorectal liver metastases

Thomas Reinert, Lena Marie Skindhoj Petersen, Tenna Vesterman Henriksen, Marie Obo Larsen, Mads Heilskov Rasmussen, Amanda Frydendahl Boll Johansen, Nadia Ogaard, Michael Knudsen, Iver Nordentoft, Soren Vang, Soren Rasmus Palmelund Krag, Anders Riegels Knudsen, Frank Viborg Mortensen, Claus Lindbjerg Andersen

Summary: This study found that monitoring ctDNA status in plasma can detect the risk of recurrence in colorectal liver metastases patients earlier and can potentially assist in clinical decision-making in cases of indeterminate CT findings, reducing time-to-intervention.

INTERNATIONAL JOURNAL OF CANCER (2022)

Article Mathematics, Applied

On the sum of chemical reactions

Linard Hoessly, Carsten Wiuf, Panqiu Xia

Summary: This article introduces a mathematical operation for summing chemical reactions and studies its algebraic properties and applications in stochastic reaction networks.

EUROPEAN JOURNAL OF APPLIED MATHEMATICS (2022)

Article Biology

Unsupervised detection of fragment length signatures of circulating tumor DNA using non-negative matrix factorization

Gabriel Renaud, Maibritt Norgaard, Johan Lindberg, Henrik Gronberg, Bram De Laere, Jorgen Bjerggaard Jensen, Michael Borre, Claus Lindbjerg Andersen, Karina Dalsgaard Sorensen, Lasse Maretty, Soren Besenbacher

Summary: This study proposes a novel unsupervised method, non-negative matrix factorization (NMF), to accurately infer tumor fragment length distribution and detect cancer using cell-free DNA (cfDNA) sequencing. The study demonstrates that NMF can accurately infer tumor fragment length distribution and correlate with ctDNA levels. It also shows that using NMF on genomic regions can identify fragment length signatures associated with open chromatin.

ELIFE (2022)

Editorial Material Oncology

ASO Visual Abstract: ctDNA for Recurrence Risk Assessment in Patients Treated with Neoadjuvant Treatment-A Systematic Review and Meta-analysis

Mikail Gogenur, Noor Al-Huda Hadi, Camilla Qvortrup, Claus Lindbjerg Andersen, Ismail Gogenur

ANNALS OF SURGICAL ONCOLOGY (2022)

Editorial Material Oncology

ctDNA-guided adjuvant chemotherapy for colorectal cancer-ready for prime time?

Claus L. Andersen, Ellen Heitzer

CANCER CELL (2022)

Article Multidisciplinary Sciences

Transposon-activated POU5F1B promotes colorectal cancer growth and metastasis

Laia Simo-Riudalbas, Sandra Offner, Evarist Planet, Julien Duc, Laurence Abrami, Sagane Dind, Alexandre Coudray, Mairene Coto-Llerena, Caner Ercan, Salvatore Piscuoglio, Claus Lindbjerg Andersen, Jesper Bertram Bramsen, Didier Trono

Summary: The early diagnosis of colorectal cancer (CRC) is an unmet medical need. In this study, the authors characterized cancer-specific transposable element-driven transpochimeric gene transcripts (TcGTs) and identified the role of POU5F1B in CRC growth and metastasis. They found that the expression of POU5F1B, driven by a primate-specific endogenous retroviral promoter, is a strong negative prognostic biomarker in CRC. They also demonstrated that POU5F1B promotes CRC cell proliferation and metastatic potential by inducing intracellular signaling events and the release of trans-acting factors involved in cell growth and adhesion. These findings provide interesting leads for the development of cancer therapies.

NATURE COMMUNICATIONS (2022)

Article Genetics & Heredity

Estimation of site frequency spectra from low-coverage sequencing data using stochastic EM reduces overfitting, runtime, and memory usage

Malthe Sebro Rasmussen, Genis Garcia-Erill, Thorfinn Sand Korneliussen, Carsten Wiuf, Anders Albrechtsen

Summary: This article presents a stochastic expectation-maximization algorithm for inferring the site frequency spectrum from NGS data, addressing the bias, high computational demands, and overfitting issues. The algorithm significantly reduces runtime and enables estimation with constant, trivial RAM usage, while improving downstream inference.

GENETICS (2022)

Article Multidisciplinary Sciences

MSIMEP: Predicting microsatellite instability from microarray DNA methylation tumor profiles

Martin Santamarina-Garcia, Jenifer Brea-Iglesias, Jesper Bertram Bramsen, Mar Fuentes-Losada, Francisco Javier Caneiro-Gomez, Jose Angel Vazquez-Bueno, Hector Lazare-Iglesias, Natalia Fernandez-Diaz, Laura Sanchez-Rivadulla, Yoel Z. Betancor, Miriam Ferreiro-Pantin, Pablo Conesa-Zamora, Jose Ramon Antunez-Lopez, Masahito Kawazu, Manel Esteller, Claus Lindbjerg Andersen, Jose M. C. Tubio, Rafael Lopez-Lopez, Juan Ruiz-Banobre

Summary: Deficient DNA MMR activity leads to tumors with hypermutator phenotype called microsatellite instability (MSI). MSI has become an important predictive biomarker for anti-PD-1 therapies in various tumor types. In this study, we developed and validated MSIMEP, a computational tool for predicting MSI status from microarray DNA methylation tumor profiles of colorectal cancer samples. We demonstrated the high performance of MSIMEP in predicting MSI in different colorectal cancer cohorts and tested its consistency in other tumor types. The MSIMEP models showed better performance compared to a MLH1 promoter methylation-based model in colorectal cancer.

ISCIENCE (2023)

Article Public, Environmental & Occupational Health

Identifying Recurrences Among Non-Metastatic Colorectal Cancer Patients Using National Health Data Registries: Validation and Optimization of a Registry-Based Algorithm in a Modern Danish Cohort

Jesper Nors, Trine Block Mattesen, Deirdre Cronin -Fenton, Aurelie Mailhac, Jesper Bertram Bramsen, Kare Andersson Gotschalck, Rune Erichsen, Claus Lindbjerg Andersen

Summary: The purpose of this study is to revalidate a registry-based algorithm for identifying colorectal cancer recurrence in a contemporary cohort and to investigate the accuracy of estimating the time to recurrence. The algorithm detects recurrence based on diagnosis codes, receipt of chemotherapy, or pathological tissue assessment. In the validation cohort, the algorithm showed a sensitivity of 94% and a specificity of 98%. Restricting the algorithm to chemotherapy codes from oncology departments improved its positive predictive value. Overall, this algorithm is suitable for future observational studies.

CLINICAL EPIDEMIOLOGY (2023)

Article Oncology

Impact of Whole Genome Doubling on Detection of Circulating Tumor DNA in Colorectal Cancer

Jonas Kabel, Tenna Vesterman Henriksen, Christina Demuth, Amanda Frydendahl, Mads Heilskov Rasmussen, Jesper Nors, Nicolai J. Birkbak, Anders Husted Madsen, Uffe S. Love, Per Vadgaard Andersen, Thomas Kolbro, Alessio Monti, Ole Thorlacius-Ussing, Mikail Gogenur, Jeppe Kildsig, Nis Hallundbaek Schlesinger, Peter Bondeven, Lene Hjerrild Iversen, Kare Andersson Gotschalck, Claus Lindbjerg Andersen

Summary: Investigating the impact of tumor cell whole-genome doubling (WGD) on the detection of circulating tumor DNA (ctDNA), it was found that tumors with WGD have a higher likelihood of ctDNA detection. This is particularly significant for early-stage cancer. The study suggests that ctDNA is a promising biomarker for the early detection of cancer and residual disease.

CANCERS (2023)

Review Oncology

Cell-free DNA approaches for cancer early detection and interception

Jamie E. Medina, Nicholas C. Dracopoli, Peter B. Bach, Anna Lau, Robert B. Scharpf, Gerrit A. Meijer, Claus Lindbjerg Andersen, Victor E. Velculescu

Summary: This study evaluates progress in early cancer detection tests and discusses the challenges in demonstrating their clinical utility before implementing them into routine clinical care.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)

Article Multidisciplinary Sciences

A reaction network scheme for hidden Markov model parameter learning

Carsten Wiuf, Abhishek Behera, Abhinav Singh, Manoj Gopalkrishnan

Summary: In this study, we propose a novel reaction network scheme called the Baum-Welch (BW) reaction network for learning parameters of hidden Markov models (HMMs). The scheme encodes all variables using separate species and each reaction in the scheme changes only one molecule from one species to another. We show that the BW algorithm and the reaction network scheme have the same fixed points and that the expectation step and the maximization step of the reaction network converge fast and compute the same values as the E-step and M-step of the BW algorithm. Simulation results demonstrate that our reaction network learns the same parameters as the BW algorithm and the log-likelihood increases continuously.

JOURNAL OF THE ROYAL SOCIETY INTERFACE (2023)

Article Biotechnology & Applied Microbiology

DREAMS: deep read-level error model for sequencing data applied to low-frequency variant calling and circulating tumor DNA detection

Mikkel H. Christensen, Simon O. Drue, Mads H. Rasmussen, Amanda Frydendahl, Iben Lyskjaer, Christina Demuth, Jesper Nors, Kare A. Gotschalck, Lene H. Iversen, Claus L. Andersen, Jakob Skou Pedersen

Summary: Circulating tumor DNA detection using NGS data shows potential for cancer identification and characterization. However, distinguishing tumor signal from errors in blood is challenging. We propose DREAMS, a method for estimating error rates and develop statistical methods for variant calling and cancer detection. Evaluation on colorectal cancer patients demonstrates that DREAMS outperforms current methods.

GENOME BIOLOGY (2023)

No Data Available